TCMBANKIN023462 |
cucurbic acid |
cucurbicacid; SCHEMBL6727796 |
C12H20O3 |
212.28 g/mol |
CCC=CCC1C(CCC1O)CC(=O)O |
TCMBANKIN027693 |
16,17-dihydroxy-16beta-(i)-kauran-19-oic acid |
|
C21H34O4 |
|
CC12CCCC(C1CCC34C2CCC(C3)C(C4)(CO)O)(C)C(=O)OC |
TCMBANKIN034812 |
cucurbitacin a |
|
C32H46O9 |
574.7 g/mol |
CC(=O)OC(C)(C)C=CC(=O)C(C)(C1C(CC2(C1(CC(=O)C3(C2CC=C4C3CC(C(=O)C4(C)C)O)CO)C)C)O)O |
TCMBANKIN045565 |
7beta,12alpha-Dihydroxykaurenolide |
7β,12α-dihydroxykaurenolide |
C20H28O4 |
332.4 g/mol |
C1([H])([H])C([H])([H])C([H])([H])[C@]2(C([H])([H])[H])[C@]([H])([C@@]([H])(OC3=O)[C@]([H])(O[H])[C@@]4(C([H])([H])[C@]([H])(C(=C([H])[H])C4([H])[H])[C@@]([H])(O[H])C5([H])[H])[C@]25[H])[C@@]13C([H])(
[H])[H] |
TCMBANKIN047298 |
3-o-p-aminobenzoyl-29-o-benzoylmultiflora-7,9(11)-diene-3α,29-diol |
|
C44H57NO4 |
|
CC1(C(CCC2(C1CC=C3C2=CCC4(C3(CCC5(C4CC(CC5)(C)COC(=O)C6=CC=CC=C6)C)C)C)C)OC(=O)C7=CC=C(C=C7)N)C |
TCMBANKIN050389 |
3-o-p-aminobenzoyl-29-o-benzoylmultiflora-8-ene-3α,7β,29-triol |
|
C44H59NO5 |
|
CC1(C(CCC2(C1CC(C3=C2CCC4(C3(CCC5(C4CC(CC5)(C)COC(=O)C6=CC=CC=C6)C)C)C)O)C)OC(=O)C7=CC=C(C=C7)N)C |
TCMBANKIN058175 |
hydroxyresveratrol |
2,4,3',5'-Tetrahydroxystilbene; oxyresveratrol ; Cudranin; oxyresveratrol; 2,3',4,5'-tetrahydroxystilbene; trans-2,3',4,5'-tetrahydroxystilbene; TETRAHYDROXYSTILBENE; Puag-haad; ACon1_001063; 1,3-Benzenediol, 4-(2-(3,5-dihydroxyphenyl)ethenyl)-, (E)-; 4-[(E)-2-(3,5-dihydroxyphenyl)vinyl]benzene-1,3-diol; NSC 315550; 4-[(E)-2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,3-diol; 4-[2-(3,5-dihydroxyphenyl)vinyl]resorcinol; Oxyresveratrol; cudranin; C10273; 1,3-Benzenediol, 4-(2-(3,5-dihydroxyphenyl)ethenyl)-; MEGxp0_001057; 4-[2-(3,5-dihydroxyphenyl)vinyl]benzene-1,3-diol; 4-[(E)-2-(3,5-dihydroxyphenyl)vinyl]resorcinol; NSC315550; 4-[2-(3,5-dihydroxyphenyl)ethenyl]benzene-1,3-diol; 4721-07-7; 29700-22-9 |
C14H12O4 |
244.24 g/mol |
C1=CC(=C(C=C1O)O)C=CC2=CC(=CC(=C2)O)O |
TCMBANKIN058642 |
cucurbitine |
3-Pyrrolidinecarboxylicacid, 3-amino-, (3S)-; (3R)-3-amino-3-pyrrolidinecarboxylic acid; AJ-76966; (3R)-3-aminopyrrolidine-3-carboxylic acid; EN300-86270; AC1Q4UAC; Cucurbitine; (S)-3-Aminopyrrolidine-3-carboxylic acid; (3S)-(?)-Cucurbitine; J-002967; 113473-30-6; BG00900626; 3-Pyrrolidinecarboxylic acid, 3-amino-, (R)-; (S)-(-)-Cucurbitine; 6807-92-7; Z2135; AK433912; 3-Pyrrolidinecarboxylic acid, 3-amino-, (3S)- (9CI); FCH932429; ZINC20286389; C10140; CTK0H2942; AKOS006237198; (3S)-3-aminopyrrolidine-3-carboxylic acid;pumpkin;cucurbitin |
C5H10N2O2 |
130.15 g/mol |
C1CNCC1(C(=O)O)N |
TCMBANKIN058901 |
zeatin |
(E)-2-methyl-4-(7H-purin-6-ylamino)but-2-en-1-ol; NCGC00142544-01; Zeatin; Z0876_SIGMA; Z1626_SIGMA; 2-methyl-4-(9H-purin-6-ylamino)but-2-en-1-ol; CHEBI:16522; TNP00322; BRN 0616241; trans-Zeatin-8-14C; N6-(4-Hydroxy-3-methyl-2-buten-1-yl)adenine; Zeatine; trans-Zeatin hydrochloride; (E)-2-methyl-4-(purin-6-ylamino)-2-buten-1-ol; C00371; SMR000471895; 96088_FLUKA; 2-buten-1-ol, 2-methyl-4-(9H-purin-6-ylamino)-, (2E)-; ST057583; 1637-39-4; Z0164_SIGMA; Z2753_SIGMA; NCGC00017372-01; (E)-2-methyl-4-(1H-purin-6-ylamino)-2-buten-1-ol; 2-BUTEN-1-OL, 2-METHYL-4-(PURIN-6-YLAMINO)-, (E)-; MLS001074742; 2-Buten-1-ol, 2-methyl-4-(1H-purin-6-ylamino)-, (E)-; CHEBI:15333; (E)-Zeatin; 6-[4-hydroxy-3-methyl-but-2-enylamino]adenine; 2-methyl-4-(7H-purin-6-ylamino)but-2-en-1-ol; InChI=1/C10H13N5O/c1-7(4-16)2-3-11-9-8-10(13-5-12-8)15-6-14-9/h2,5-6,16H,3-4H2,1H3,(H2,11,12,13,14,15)/b7-2; (2E)-2-methyl-4-(9H-purin-6-ylamino)but-2-en-1-ol; trans-Zeatin; ZINC04492895; ZINC01532631; N6-(4-Hydroxyisopentenyl)adenine; 6-(4-Hydroxy-3-methylbut-2-enylamino)purine; (E)-2-Methyl-4-(1H-purin-6-ylamino)but-2-en-1-ol; 2-methyl-4-(1H-purine-6-ylamino)-2-buten-1-ol; trans-zeatin |
C10H13N5O |
219.24 g/mol |
CC(=CCNC1=NC=NC2=C1NC=N2)CO |
TCMBANKIN059703 |
Zeaxanthin |
|
C40H56O2 |
568.87 |
CC1=C(C(CC(C1)O)(C)C)C=CC(=CC=CC(=CC=CC=C(C)C=CC=C(C)C=CC2=C(CC(CC2(C)C)O)C)C)C |